لا تُقدم XM خدماتها لمواطني الولايات المتحدة الأمريكية.
G
G

Gilead


أخبار

U.S. stocks weekly: Heat advisory

RPT-BUZZ-U.S. stocks weekly: Heat advisory Repeats from Friday with no changes to text. Updates chart ** S&P 500 .SPX gains third consecutive week, advances 0.6% .N ** Indeed, benchmark index heating up just as summer solstice hits ** And Nasdaq .IXIC ekes out third-straight weekly gain, though it may be flying on fumes ** Most sectors toasty; Consumer Discretionary and Energy bake most, while Tech and bond-proxies cool off; this, as Growth .IGX was on pace for its best month vs Value .IVX in 24
A
A
G
M
N
U
U

U.S. CarMax, Eli Lilly, MicroStrategy

U.S. RESEARCH ROUNDUP-CarMax, Eli Lilly, MicroStrategy June 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CarMax, Eli Lilly and MicroStrategy, on Monday. HIGHLIGHTS * CarMax Inc KMX.N : RBC raises target price to $75 from $73 * Eli Lilly LLY.N : Jefferies raises target price to $1,015 from $994 * MicroStrategy Inc MSTR.O : Canaccord Genuity cuts target price to $1,826 from $2,047 * Sharecare Inc SHCR.O : Canacco
A
A
B
D
G
M
N
V
E
F
T
E
P
R
T
C
C
I

U.S. stocks weekly: Heat advisory

BUZZ-U.S. stocks weekly: Heat advisory ** S&P 500 .SPX gains third consecutive week, advances 0.6% .N ** Indeed, benchmark index heating up just as summer solstice hits ** And Nasdaq .IXIC ekes out third-straight weekly gain, though it may be flying on fumes ** Most sectors toasty; Consumer Discretionary and Energy bake most, while Tech and bond-proxies cool off; this, as Growth .IGX was on pace for its best month vs Value .IVX in 24 years, before stumbling relatively last 3 trading days of the
A
A
G
M
N
U
U

U.S. STOCKS FactSet, Ryan Specialty, Sarepta

BUZZ-U.S. STOCKS ON THE MOVE-FactSet, Ryan Specialty, Sarepta Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set for a muted open on Friday as chip stocks lost ground, with focus on data from the manufacturing and services sectors for more clues on the health of the world's largest economy.
A
B
C
G
M
N
N
U
U
C
F

U.S. STOCKS Apple, Gilead, Spirit Aerosystems

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Gilead, Spirit Aerosystems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
N
S
R
U
E
C

Wall Street set for muted open as investors await business survey data

US STOCKS-Wall Street set for muted open as investors await business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Spirit Aero up following report of Boeing nearing buyout deal Sarepta surges on expanded use of gene therapy Gilead gains after long-acting HIV drug trial success S&P 500 crossed 5,500 points on Thursday Futures down: Dow 0.12%, S&P 500 0.08%, Nasdaq 0.01% Updated at 8:45 a.m.
A
B
G
M
N
Q
U
U
U

Gilead set to extend gains on success of long-acting HIV drug trial

BUZZ-Gilead set to extend gains on success of long-acting HIV drug trial Updates ** Shares of drugmaker Gilead Sciences GILD.O rise 3.2% to $70.7 premarket following HIV drug trial success reported on Thursday ** Stock closed 5% higher a day earlier on the news, after rising as much as 8.5% during the session ** Co's late-stage study showed injectable drug lenacapavir was more effective in preventing HIV infection in women versus its existing daily pill Truvada ** There were zero incidents of HI
G

Wall Street futures muted ahead of business survey data

US STOCKS-Wall Street futures muted ahead of business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Spirit Aero up following report of Boeing nearing buyout deal Sarepta surges on expanded use of gene therapy Gilead gains after long-acting HIV drug trial success Futures: Dow, S&P 500, Nasdaq flat Updated at 7:29 a.m.
B
G
M
M
N
Q
U
U
U

U.S. STOCKS Apple, Gilead, Spirit Aerosystems

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Gilead, Spirit Aerosystems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
N
R
U
C

Wall Street futures edge lower ahead of business survey data

US STOCKS-Wall Street futures edge lower ahead of business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Futures lower: Dow 0.07%, S&P 500 0.15%, Nasdaq 0.12% June 21 (Reuters) - U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
Q
U
U
U

Gilead up over long-acting HIV drug trial success

BUZZ-Gilead up over long-acting HIV drug trial success ** Shares of drugmaker Gilead Sciences GILD.O rise 7.3% to $73.5 premarket over Thursday's HIV drug trial success ** Co's late-stage study showed its injectable drug, lenacapavir, was more effective in preventing HIV infection in women versus its existing daily pill Truvada, sending GILD's shar
G

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +8.3% Advanced Micro Devices Inc AMD.OQ +5.2% Sirius XM Holdings Inc SIRI.OQ +3.6% Cognizant Technology Solutions Corp CTSH.OQ +3.5% Workday Inc WDAY.OQ +3.1% Bottom Performers Percent Change Qualcomm Inc QCOM.OQ -5.1% Micron Technology Inc MU.OQ -5.1% Microchip Technology Inc MCHP.OQ -4.5% ON Semiconductor Corp ON.OQ -4.2% Broadcom Inc AVGO.OQ -3.3% Th
B
C
G
M
Q
A
M
O
S
U
W

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +8.4% Accenture PLC ACN.N +7.9% Epam Systems Inc EPAM.N +6.3% Salesforce Inc CRM.N +5.1% WestRock Co WRK.N +4.8% Bottom Performers Percent Change Jabil Inc JBL.N -11.2% Enphase Energy Inc ENPH.OQ -8.7% Chipo
C
G
M
Q
S
U
E
W

Gilead gains as long-acting HIV drug superior to daily pill Truvada in study

BUZZ-Gilead gains as long-acting HIV drug superior to daily pill Truvada in study Updates ** Shares of drugmaker Gilead Sciences GILD.O rise 8.4% to $68.5 ** GILD reports a late-stage study of its injectable drug, lenacapavir, showed superior efficacy in preventing HIV infection in women compared to co's existing daily pill Truvada * * The study was stopped early by an independent committee as it exceeded efficacy expectations ** There were zero incidents of HIV infection among women who receive
G

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq hit record highs on Thursday, boosted by strong gains in Nvidia, while investors assessed recent economic data and commentary from Federal Reserve officials to gauge the timing of interest-rate cuts this year.
G
K
M
N
U
U
D
A
D

U.S. STOCKS Allstate, MicroStrategy, AutoZone

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The benchmark S&P 500 touched a record high on Thursday, boosted by strong gains in Nvidia, while investors assessed the recent economic data and commentary from Federal Reserve officials to gauge the timing for interest rate cuts this year.
G
K
N
A
U
U
D
D

Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +8.0% Advanced Micro Devices Inc AMD.OQ +6.2% Cognizant Technology Solutions Corp CTSH.OQ +3.8% Workday Inc WDAY.OQ +2.9% Charter Communications Inc CHTR.OQ +2.1% Bottom Performers Percent Change Qualcomm Inc QCOM.OQ -4.3% Micron Technology Inc MU.OQ -3.4% Microchip Technology Inc MCHP.OQ -3.2% ON Semiconductor Corp ON.OQ -3.0% Copart Inc CPRT.OQ -2.3%
C
C
G
M
Q
A
M
O
U
W
C

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +7.9% Accenture PLC ACN.N +6.9% Advanced Micro Devices Inc AMD.OQ +6.3% Super Micro Computer Inc SMCI.OQ +6.2% Epam Systems Inc EPAM.N +6.1% Bottom Performers Percent Change Jabil Inc JBL.N -8.5% Enphase Ene
C
G
Q
A
U
E
V

Gilead up as long-acting HIV drug superior to daily pill Truvada in study

BUZZ-Gilead up as long-acting HIV drug superior to daily pill Truvada in study ** Shares of drugmaker Gilead Sciences GILD.O rise about 3% to $65 premarket ** GILD reported a late-stage study of its injectable drug, lenacapavir, which showed superior efficacy in preventing HIV infection in women compared to co's existing daily pill Truvada ** There were zero incidents of HIV infection among women who received lenacapavir - GILD ** Lenacapavir was well-tolerated with no significant or new safety
G

Gilead's long-acting HIV drug superior to daily pill Truvada in study

UPDATE 3-Gilead's long-acting HIV drug superior to daily pill Truvada in study Adds executive comments in paragraphs 4 and 8 By Mariam Sunny June 20 (Reuters) - Gilead Sciences GILD.O said on Thursday a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill Truvada, sending the company's shares up over 8%.
G



الشروط

الأصول الشائعة

إخلاء المسؤولية: تتيح كيانات XM Group خدمة تنفيذية فقط والدخول إلى منصة تداولنا عبر الإنترنت، مما يسمح للشخص بمشاهدة و/أو استخدام المحتوى المتاح على موقع الويب أو عن طريقه، وهذا المحتوى لا يراد به التغيير أو التوسع عن ذلك. يخضع هذا الدخول والاستخدام دائماً لما يلي: (1) الشروط والأحكام؛ (2) تحذيرات المخاطر؛ (3) إخلاء المسؤولية الكامل. لذلك يُقدم هذا المحتوى على أنه ليس أكثر من معلومات عامة. تحديداً، يرجى الانتباه إلى أن المحتوى المتاح على منصة تداولنا عبر الإنترنت ليس طلباً أو عرضاً لدخول أي معاملات في الأسواق المالية. التداول في أي سوق مالي به مخاطرة عالية برأس مالك.

جميع المواد المنشورة على منصة تداولنا مخصصة للأغراض التعليمية/المعلوماتية فقط ولا تحتوي - ولا ينبغي اعتبار أنها تحتوي - على نصائح أو توصيات مالية أو ضريبية أو تجارية، أو سجلاً لأسعار تداولنا، أو عرضاً أو طلباً لأي معاملة في أي صكوك مالية أو عروض ترويجية مالية لا داعي لها.

أي محتوى تابع للغير بالإضافة إلى المحتوى الذي أعدته XM، مثل الآراء، والأخبار، والأبحاث، والتحليلات والأسعار وغيرها من المعلومات أو روابط مواقع تابعة للغير وواردة في هذا الموقع تُقدم لك "كما هي"، كتعليق عام على السوق ولا تعتبر نصيحة استثمارية. يجب ألا يُفسر أي محتوى على أنه بحث استثماري، وأن تلاحظ وتقبل أن المحتوى غير مُعدٍ وفقاً للمتطلبات القانونية المصممة لتعزيز استقلالية البحث الاستثماري، وبالتالي، فهو بمثابة تواصل تسويقي بموجب القوانين واللوائح ذات الصلة. فضلاً تأكد من أنك قد قرأت وفهمت الإخطار بالبحوث الاستثمارية غير المستقلة والتحذير من مخاطر المعلومات السابقة، والذي يمكنك الاطلاع عليه هنا.

تحذير المخاطر: رأس مالك في خطر. المنتجات التي تستخدم الرافعة قد لا تكون مناسبة للجميع. يرجى الاطلاع على تنبيه المخاطر.